Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.83732 | 35 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.84892 | 37 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.82463 | 36 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.80192 | 38 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.83004 | 38 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.88772 | 36 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.85082 | 35 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.99585 | 43 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.83703 | 38 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.81841 | 37 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.83435 | 37 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.86447 | 39 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.83747 | 37 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.82472 | 36 |